BioFortis adds former Pfizer, VP and Global Head of Translational Medicine to Board:

"Bruce brings critical experience that will help guide BioFortis as we leverage our success in supporting translational research into the pharmaceutical sector,” says Jian Wang, CEO of BioFortis. “We are pleased to have attracted a board member of Dr. Littman’s caliber.”

read more here >>

Backup Compound Strategies: Commercial and Tactical Considerations – Overview
read more here >>

Bontan changes its name to Portage Biotech Inc. and jurisdiction to BVI
read more here >>

Careers in Translational Medicine
read more here >>

A Shifting Drug Industry Means New Opportunities in Translational Research
read more here >>

John Sterling talks with Bruce H. Littman, M.D., Vice President and Head, Global Translational Medicine, Pfizer Global Research and Development about translational medicine. (4/20/2006)
read more here >>

Business Week- Making Personalized Medicine Pay
read more here >>